# Immix Biopharma Inc. (IMMX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $13.91, market value $990 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Immix Biopharma Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 4.3×**. The shares trade at 4.3× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -3.9%** (5-yr avg -15.3%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -31.4%**. Return on equity is negative because earnings are negative.

## Growth
- **EPS growth (1 yr): -17.1%**. Earnings per share fell 17.1%.

## Financial health
- **Current ratio: 10.01** (quick 10.01). Current assets cover the next year's liabilities 10.01 times.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Immix Biopharma Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (8 analysts). 8 analysts cover Immix Biopharma Inc.; the consensus is strong_buy, with an average price target of $20.27 (+46% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 535.2%** (YTD 166.0%, 3-mo 75.4%). The shares are up 535.2% over twelve months including dividends.
- **From 52-week high: -7.9%** (617.0% above the low). Trading 8% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 67**. An RSI of 67 is neutral.
- **Beta (1 yr): 1.46** (volatility 85%). Beta of 1.46 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=IMMX · Page: https://foliofundamentals.com/stocks/immx

Not investment advice.